Ajay Padmanaban

Chennai, TN, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A Multicenter Clinical Diagnostic Accuracy Study of SureStatus, an Affordable, WHO Emergency Use-Listed, Rapid, Point-Of-Care Antigen-Detecting Diagnostic Test for SARS-CoV-2.

A Multicenter Clinical Diagnostic Accuracy Study of SureStatus, an Affordable, WHO Emergency Use-Listed, Rapid, Point-Of-Care Antigen-Detecting Diagnostic Test for SARS-CoV-2.

Journal: Microbiology spectrum

Published: September 06, 2022

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia.

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia.

Journal: Intensive care medicine

Published: February 07, 2022

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.

Journal: JAMA

Published: October 21, 2021

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial.

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial.

Journal: Intensive care medicine

Published: September 27, 2021

Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan.

Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan.

Journal: Acta anaesthesiologica Scandinavica

Published: January 28, 2021

Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysis.

Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysis.

Journal: Acta anaesthesiologica Scandinavica

Published: January 28, 2021

Feasibility and Safety of Peripheral Intravenous Administration of Vasopressor Agents in Resource-limited Settings.

Feasibility and Safety of Peripheral Intravenous Administration of Vasopressor Agents in Resource-limited Settings.

Journal: Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures)

Published: January 09, 2020

Fabrication of Ag@Co-Al Layered Double Hydroxides Reinforced poly(o-phenylenediamine) Nanohybrid for Efficient Electrochemical Detection of 4-Nitrophenol, 2,4-Dinitrophenol and Uric acid at Nano Molar Level.

Fabrication of Ag@Co-Al Layered Double Hydroxides Reinforced poly(o-phenylenediamine) Nanohybrid for Efficient Electrochemical Detection of 4-Nitrophenol, 2,4-Dinitrophenol and Uric acid at Nano Molar Level.

Journal: Scientific reports

Published: March 05, 2019

Bifunctional hexagonal Ni/NiO nanostructures: influence of the core-shell phase on magnetism, electrochemical sensing of serotonin, and catalytic reduction of 4-nitrophenol.

Bifunctional hexagonal Ni/NiO nanostructures: influence of the core-shell phase on magnetism, electrochemical sensing of serotonin, and catalytic reduction of 4-nitrophenol.

Journal: Nanoscale advances

Published: November 12, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026